Provisions of the Supreme People's Court on Several Issues concerning the Applicable Law in the Trial of Civil Cases concerning Patent Rights Disputes Related to Drugs Applications for Registration - Fondee IP Law LLC

This page is reconstructed from the old legal archive entry rather than rewritten as a fresh editorial piece. The archived source preserved the Supreme People’s Court notice and the legal-text excerpt, so this detail page follows that original archive format and stays honest about its provenance.

• Release information: adopted at the 1839th meeting of the Judicial Committee of the Supreme People’s Court on May 24, 2021, published on July 4, 2021 as Legal Interpretation [2021] No. 13, and effective from July 5, 2021.
• Scope: addresses civil cases involving patent rights disputes related to drugs applying for registration.
• Core rule: clarifies first-instance jurisdiction for disputes asking whether a claim falls within the scope of patent protection, and sets out the litigation path for drug-registration related patent issues.
• Procedure: covers filing materials, coordination with the relevant administrative platform, and effective service arrangements through listed contact details.
• Archive note: the old page presents the notice and the text together, so the reconstructed page keeps that legal-archive structure.

If you want a more article-like rendering, we can expand this strictly from the archived local source text.